Westin Ottawa Hotel , Ottawa, Canada
Nov 3 2010 - Nov 5 2010
CALL FOR ABSTRACTS for Presentations (details on page 3) for Posters (details on page 2) All abstracts are due by October 18, 2010 PROGRAM OVERVIEW The biopharmaceutical community is experiencing a paradigm shift in drug development. Important global changes are occurring with respect to regulatory oversight to clinical trial design and execution. Several factors infl uencing these changes include: new scientifi c approaches; biomarkers and individualized medicine; healthcare reform and the interplay between safety pharmacovigilance and eff ectiveness research. In order to remain competitive, Canada will need to foster innovation in these areas and facilitate market access to medicines. World market dynamics have led to increased opportunities for both industry and regulators to share information while at the same time, introducing new challenges regarding privacy and/or confi dentiality and clinical trial competitiveness. The program will highlight information on improving effi ciency in the running of clinical trials; discussion of streamlining federal and provincial regulatory and formulary approvals; and advice on strategies to overcome obstacles.
|